Literature DB >> 6992155

Membrane transport of alkylating agents.

G J Goldenberg, A Begleiter.   

Abstract

Mesh:

Substances:

Year:  1980        PMID: 6992155     DOI: 10.1016/0163-7258(80)90048-0

Source DB:  PubMed          Journal:  Pharmacol Ther        ISSN: 0163-7258            Impact factor:   12.310


× No keyword cloud information.
  9 in total

1.  Alkylating agent resistance: in vitro studies with human cell lines.

Authors:  E Frei; C A Cucchi; A Rosowsky; R Tantravahi; S Bernal; T J Ervin; R M Ruprecht; W A Haseltine
Journal:  Proc Natl Acad Sci U S A       Date:  1985-04       Impact factor: 11.205

Review 2.  Mechanisms mediating the vesicant actions of sulfur mustard after cutaneous exposure.

Authors:  Michael P Shakarjian; Diane E Heck; Joshua P Gray; Patrick J Sinko; Marion K Gordon; Robert P Casillas; Ned D Heindel; Donald R Gerecke; Debra L Laskin; Jeffrey D Laskin
Journal:  Toxicol Sci       Date:  2009-10-15       Impact factor: 4.849

3.  bis-Pyridinium cyclophanes: novel ligands with high affinity for the blood-brain barrier choline transporter.

Authors:  Zhenfa Zhang; Paul R Lockman; Rajendar K Mittapalli; David D Allen; Linda P Dwoskin; Peter A Crooks
Journal:  Bioorg Med Chem Lett       Date:  2008-08-30       Impact factor: 2.823

4.  Antitumor alkylating agents: in vitro cross-resistance and collateral sensitivity studies.

Authors:  E Frei; S A Holden; R Gonin; D J Waxman; B A Teicher
Journal:  Cancer Chemother Pharmacol       Date:  1993       Impact factor: 3.333

5.  Oral melphalan pharmacokinetics--relation to dose in patients with multiple myeloma.

Authors:  H Ehrsson; S Eksborg; A Osterborg; H Mellstedt; A Lindfors
Journal:  Med Oncol Tumor Pharmacother       Date:  1989

6.  The effect of hyperthermia in combination with melphalan on drug-sensitive and drug-resistant CHO cells in vitro.

Authors:  D A Bates; W J Mackillop
Journal:  Br J Cancer       Date:  1990-08       Impact factor: 7.640

7.  Verapamil potentiation of melphalan cytotoxicity and cellular uptake in murine fibrosarcoma and bone marrow.

Authors:  B A Robinson; R D Clutterbuck; J L Millar; T J McElwain
Journal:  Br J Cancer       Date:  1985-12       Impact factor: 7.640

8.  Cytokinetic factors in drug resistance of Lewis lung carcinoma: comparison of cells freshly isolated from tumours with cells from exponential and plateau-phase cultures.

Authors:  G J Finlay; W R Wilson; B C Baguley
Journal:  Br J Cancer       Date:  1987-12       Impact factor: 7.640

Review 9.  The multiple facets of drug resistance: one history, different approaches.

Authors:  Evandro Luís Niero; Bianca Rocha-Sales; Camila Lauand; Beatriz Araujo Cortez; Marcelo Medina de Souza; Paula Rezende-Teixeira; Marcel Shiniti Urabayashi; Adam Arai Martens; Jorge Henrique Neves; Gláucia Maria Machado-Santelli
Journal:  J Exp Clin Cancer Res       Date:  2014-04-28
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.